Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence (Q40980949)

25 September 2017

1 reference

title

Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence (English)

1 reference

25 September 2017

1 reference

P A LeDuc

1

1 reference

25 September 2017

G Mittleman

series ordinal

2

1 reference

25 September 2017

publication date

1 October 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

121

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

407-427

1 reference

Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Overview: maintenance therapy in psychiatry: I. Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Medical and psychiatric complications of cocaine abuse with possible points of pharmacological treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Crack/cocaine abusers in the general hospital: assessment and initiation of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Cocaine as a risk factor for acute dystonic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Concordance of Three Measures of Cocaine Use in an Arrestee Population: Hair, Urine, and Self-report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Perspectives on a time-dependent model of neuroleptic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Amphetamine use and abuse in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Unrecognized cocaine use among schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Substance use in young adults with schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Antipsychotic drug use in the United States, 1976-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Neurobiological vulnerability to low-dose amphetamine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

Cocaine/"crack" dependence among psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02246489

The pharmacological and anatomical substrates of the amphetamine response in the rat

21 January 2018

1 reference

12 December 2020

Substance Abuse in an Inpatient Psychiatric Sample

1 reference

12 December 2020

Dextroamphetamine. Evaluation of psychomimetic properties in man

1 reference

12 December 2020

Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function

1 reference

12 December 2020

Recent psychostimulant use in hospitalized schizophrenics

1 reference

12 December 2020

Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy

1 reference

12 December 2020

Cocaine abuse among schizophrenic patients.

1 reference

12 December 2020

Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations.

1 reference

12 December 2020

The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

1 reference

12 December 2020

A psychomotor stimulant theory of addiction.

1 reference

12 December 2020

Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers.

1 reference

12 December 2020

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

1 reference

12 December 2020

Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs

1 reference

12 December 2020

Significance of cocaine history in schizophrenia

1 reference

12 December 2020

Neurochemical and genetic bases of psychopathology: Current status

1 reference

12 December 2020

GC/MS assays for abused drugs in body fluids.

1 reference

12 December 2020

Unregulated self-medication in an ambulatory surgery population.

1 reference

12 December 2020

Non-random relation between drugs of abuse and psychiatric diagnosis

1 reference

12 December 2020

Individual differences in the reinforcing and subjective effects of amphetamine and diazepam

1 reference

12 December 2020

Testing for drugs of abuse. Pharmacokinetic considerations for cocaine in urine

1 reference

12 December 2020

Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment

1 reference

12 December 2020

Predicting compliance of dual diagnosis inpatients with aftercare treatment.

1 reference

12 December 2020

Dose response of prophylactic antipsychotics

1 reference

12 December 2020

Cortical dopaminergic involvement in cocaine reinforcement.

1 reference

12 December 2020

History of drug abuse and dangerous behavior in inpatient schizophrenics

1 reference

12 December 2020

Validation of self-report: the research record

1 reference

12 December 2020

Psychopathology in chronic cocaine abusers.

1 reference

12 December 2020

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

1 reference

12 December 2020

Cocaine and Tourette's syndrome.

1 reference

12 December 2020

Prolonged presence of metabolite in urine after compulsive cocaine use.

1 reference

12 December 2020

Histories of substance abuse in patients with postpsychotic depressions

1 reference

12 December 2020

Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.

1 reference

12 December 2020

Thought disorder in mania and schizophrenia evaluated by Bannister's grid test for schizophrenic thought disorder

1 reference

12 December 2020

High Prevalence of Recent Cocaine Use and the Unreliability of Patient Self-report in an Inner-city Walk-in Clinic

1 reference

12 December 2020

Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys.

1 reference

12 December 2020

Neuroleptic reduction of cocaine-induced paranoia but not euphoria?

1 reference

12 December 2020

Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics

1 reference

12 December 2020

Behavioural and biochemical alterations following haloperidol treatment and withdrawal: The animal model of tardive dyskinesia reexamined

1 reference

12 December 2020

An evaluation of patterns of racial bias in hair assays for cocaine: black and white arrestees compared

1 reference

12 December 2020

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

1 reference

12 December 2020

Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders

1 reference

12 December 2020

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment

1 reference

12 December 2020

Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine.

1 reference

12 December 2020

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

1 reference

12 December 2020

Relationship between self-reported drug effects and their reinforcing effects: studies with stimulant drugs.

1 reference

12 December 2020

Substance abuse among patients presenting at an inner-city psychiatric emergency room

1 reference

12 December 2020

Analytical methodology.

1 reference

12 December 2020

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

12 December 2020

Drug abuse in schizophrenia

1 reference

12 December 2020

Treatment Cost and Rehospitalization Rate in Schizophrenic Outpatients With a History of Substance Abuse

1 reference

12 December 2020

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations

1 reference

12 December 2020

Neural mechanisms of the reinforcing action of cocaine.

1 reference

12 December 2020

The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food.

1 reference

12 December 2020

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

12 December 2020

Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing

1 reference

12 December 2020

Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis

1 reference

12 December 2020

Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service.

1 reference

12 December 2020

Positive and negative symptoms: historical and conceptual aspects

1 reference

12 December 2020

Effects of cocaine on hospital course in schizophrenia.

1 reference

12 December 2020

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

1 reference

12 December 2020

Factors that predict individual vulnerability to amphetamine self-administration.

1 reference

12 December 2020

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

12 December 2020

Pharmacotherapy of cocaine abuse: preclinical development

1 reference

12 December 2020

Enhanced sensitivity to the behavioral effects of cocaine after chronic administration of D2-selective dopamine antagonists in the squirrel monkey

1 reference

12 December 2020

Prevalence estimates of substance abuse in schizophrenia and their correlates

1 reference

12 December 2020

Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

1 reference

12 December 2020

Relationship of positive and negative symptoms to cocaine abuse in schizophrenia.

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Covert outpatient drug abuse. Incidence and therapist recognition

1 reference

12 December 2020

Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology

1 reference

12 December 2020

Cellular and molecular mechanisms of drug dependence

1 reference

12 December 2020

Outpatient treatment of schizophrenia

1 reference

12 December 2020

Crisis in drug testing. Results of CDC blind study.

1 reference

12 December 2020

The neural basis of drug craving: an incentive-sensitization theory of addiction

1 reference

12 December 2020

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice

1 reference

12 December 2020

ADRENERGIC MECHANISMS AND AMPHETAMINE INDUCED ABNORMAL BEHAVIOUR

1 reference

12 December 2020

Effect of haloperidol and sulpiride on dopamine metabolism in nucleus accumbens and olfactory tubercle: a study by in vivo voltammetry

1 reference

12 December 2020

Variability in subjective responses to cocaine: initial experiences of college students.

1 reference

12 December 2020

Discrepancies between patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admission.

1 reference

12 December 2020

Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine

1 reference

12 December 2020

Hallucinogenic drugs as precipitants of schizophrenia

1 reference

12 December 2020

Modification of behavioral and neurochemical effects of cocaine by haloperidol

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246489

1 reference

Dimensions Publication ID

25 September 2017

1038618321

0 references

1 reference